Rosuvastatin Calcium Tablet
Product Images NDC 68071-3623

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 68071-3623). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3623 9)

Pdp (68071 3623 9)
Rosuvastatin 10 mg tablets packaging label from NuCare Pharmaceuticals, Inc. The label indicates 90 tablets per container. It states the active ingredient as Rosuvastatin Calcium USP equivalent to Rosuvastatin 10 mg. The label includes manufacturer information, lot number, expiration date, and storage instructions to keep at controlled temperature 68-77°F. The product is prescription only (Rx).*
FDA Label Image

Figure_1_time_jupiter (Rosuvastatin Tablets Figure 1)

Figure_1_time_jupiter (Rosuvastatin Tablets Figure 1)
A Kaplan-Meier curve showing cumulative incidence (%) over years for Rosuvastatin Calcium 10 mg and placebo groups. The graph includes hazard ratio (HR 0.56, 95% CI 0.46-0.69) and P value (<0.001). Number at risk for RSV and placebo groups is shown at several time points up to 5 years.*
FDA Label Image

Figure_2-major_jupiter (Rosuvastatin Tablets Figure 2)

Figure_2-major_jupiter (Rosuvastatin Tablets Figure 2)
Table presenting the number of events for different cardiovascular endpoints comparing Rosuvastatin 20 mg and placebo groups. It shows event counts, rates, hazard ratios with 95% confidence intervals, and p-values, alongside a hazard ratio forest plot illustrating statistical results for primary endpoints, cardiovascular death, stroke, myocardial infarction, unstable angina, and arterial revascularization.*
FDA Label Image

Figure_3_percent_dyslipidemia (Rosuvastatin Tablets Figure 3)

Figure_3_percent_dyslipidemia (Rosuvastatin Tablets Figure 3)
Box plot chart showing percent change from baseline in LDL-C levels for four statin drugs: Rosuvastatin (Crestor), Atorvastatin, Simvastatin, and Pravastatin, across multiple doses. The y-axis represents percent change, with values ranging from 0 to -75, illustrating the LDL-C reduction effects of these drugs at various dosage levels.*
FDA Label Image
FDA Label Image

Logo1 (Rosuvastatin Tablets Logo2)

FDA Label Image

Structural_formula (Rosuvastatin Tablets Structure)

Structural_formula (Rosuvastatin Tablets Structure)
Chemical structure of Rosuvastatin Calcium showing the molecular arrangement including the fluorophenyl group, pyrimidine core, sulfonyl methyl group, hydroxyl groups, and calcium ion complex.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.